Entire Site
Articles/Fact Sheets
Ask the Experts
Conference Coverage
Now Live:
Breaking Research From AIDS 2008: Podcasts, Interviews, Videos & More >>
BROWSE TOPICS IN HIV TREATMENT:
HIV Treatment: Home Page
Just Diagnosed
HIV Medications
First Steps to Treatment
HIV Drug Resistance
Switching or Stopping Treatment
Third Line/Rescue Treatment
Hepatitis C Coinfection
Women & Pregnancy
HIV Treatment for Children
Side Effects & Health Problems
Research & Experimental Drugs
HIV Treatment in the Developing World
HIV Drugs No Longer in Development
Overview
|
Capravirine
|
DAPD (Amdoxovir)
|
Lodenosine
|
T-1249
|
Other Drugs
Overview
Failed Anti-HIV Drugs
(Regularly Updated)
From aidsmap.com
Capravirine
Pfizer Drops Development of Antiretroviral Capravirine, Citing Lack of Efficacy in Trials
(July 5, 2005)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Pfizer Discontinues Development of Capravirine, for HIV/AIDS
(July 1, 2005)
From Pfizer, Inc.
Lodenosine
Lodenosine Update
(March 2000)
In
What's New
, from
Project Inform
Safety Concerns Prompt Suspension of Lodenosine Clinical Trial
(December 1999/January 2000)
In
Positive Living
, from
AIDS Project Los Angeles
Lodenosine Study Suspended
(October 1999)
In
HIV Newsline
, from San Francisco General Hospital
Othe Drugs
Incyte Halts Development of Promising New CCR5 Drug
(April 10, 2008)
From
Project Inform
GSK Discontinues Clinical Development of Investigational Protease Inhibitor Brecanavir (640385)
(December 18, 2006)
To read PDF,
click here
From GlaxoSmithKline
Development of DFC, an Investigational NRTI, Is Discontinued
(April 4, 2006)
From
The Body